PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIntraperitoneal
Intraperitoneal
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
914 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Peritoneal neoplasmsD010534——525714137148
CarcinomaD002277—C80.039321112598
Neoplasm metastasisD009362EFO_0009708—2436611876
NeoplasmsD009369—C804019611174
Postoperative painD010149—G89.18266192152
HerniaD006547—K40-K4621—44349
Ventral herniaD006555EFO_1001866K43———22426
Colonic neoplasmsD003110—C1810531421
Laparoscopic cholecystectomyD017081——1—43816
PeritonitisD010538EFO_0008588K653233615
Show 33 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ovarian neoplasmsD010051EFO_0003893C56896720—34189
Stomach neoplasmsD013274EFO_0003897C16447722—24156
Ovarian epithelial carcinomaD000077216——514716—18118
Colorectal neoplasmsD015179——373410—2193
Fallopian tube neoplasmsD005185——43277—574
AdenocarcinomaD000230——24234—551
Pancreatic neoplasmsD010190EFO_0003860C2523131—538
HyperthermiaD000084462——585—1735
FeverD005334—R50.9575—1532
Appendiceal neoplasmsD001063EFO_0003880C18.110131—629
Show 49 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MesotheliomaD008654—C45810——623
Lung neoplasmsD008175—C34.90131——215
Malignant mesotheliomaD000086002——77——214
Breast neoplasmsD001943EFO_0003869C50123———13
Esophageal neoplasmsD004938—C1575———10
Uterine cervical neoplasmsD002583——71——210
SarcomaD012509——62——29
Acute kidney injuryD058186—N1712——58
CholangiocarcinomaD018281—C22.161———7
AppendicitisD001064EFO_0007149K3714——26
Show 36 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CystadenocarcinomaD003536——6———17
Gallbladder neoplasmsD005706EFO_0004606C234———15
Bile duct neoplasmsD001650——5————5
Endometrial neoplasmsD016889EFO_0004230—4————4
Wounds and injuriesD014947—T14.81———34
Clear cell adenocarcinomaD018262——3————3
Biliary tract neoplasmsD001661—C24.92———13
Urinary bladder neoplasmsD001749—C671———23
Head and neck neoplasmsD006258——3————3
And serous mucinous cystic neoplasmsD018297——2————2
Show 56 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative complicationsD011183——————77
PneumoperitoneumD011027——————66
VomitingD014839—R11.1————44
Inguinal herniaD006552HP_0000023K40————44
InflammationD007249MP_0001845—————33
ProlapseD011391——————33
Internal herniaD000082122——————33
Acute cholecystitisD041881EFO_1001289K81.0————22
Acalculous cholecystitisD042101EFO_1000790—————22
PancreatitisD010195EFO_0000278K85————22
Show 88 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use